New York, NY (July 24, 2014) - John Gerzema of New York, New York, has been named to the National Kidney Foundation (NKF) Board of Directors.
Mr. Gerzema is a pioneer in the use of data to identify social change and help companies anticipate and adapt to new trends and demands. He is the Chairman and CEO of Y&R's Brand Asset Valuator (BAV) Consulting, as well as an author, strategist, speaker and consultant. His three books have appeared on numerous bestseller lists, including the New York Times, and his TED Talks have been viewed by hundreds of thousands of people. Mr. Gerzema received a Masters in Integrated Marketing Communications from the Medill School of Journalism and was recently inducted into the Medill Hall of Achievement.
"One in three American adults is at risk for developing kidney disease and most don't even know it because public awareness about kidney disease is low relative to other health problems," says Gerzema. "From a marketer's perspective, this reflects a brand challenge and I am committed to working with the National Kidney Foundation to increase awareness and inspire proactive behaviors to combat this growing public health epidemic."
Mr. Gerzema is dedicated to helping the NKF build awareness and educate those at risk about the importance of early detection and leading a healthy lifestyle.
"Mr. Gerzema has previously worked with the NKF on a pro-bono basis, using the BAV dataset to better understand the public's knowledge and attitude towards the NKF brand and I am pleased that he is now serving on our national Board of Directors," says Bruce Skyer, Chief Executive Officer of the National Kidney Foundation. "As a marketing expert with deep business acumen, he is an ideal partner to help elevate the NKF brand and raise awareness about the role of the kidneys and the problem of kidney disease."
The National Kidney Foundation is the leading organization in the U.S. dedicated to the awareness, prevention and treatment of kidney disease for hundreds of thousands of healthcare professionals, millions of patients and their families and tens of millions of Americans at risk. For more information, visit www.kidney.org.